When.com Web Search

  1. Ads

    related to: what is enteropeptidase d good for cancer patients

Search results

  1. Results From The WOW.Com Content Network
  2. Enteropeptidase - Wikipedia

    en.wikipedia.org/wiki/Enteropeptidase

    Enteropeptidase (also called enterokinase) is an enzyme produced by cells of the duodenum and is involved in digestion in humans and other animals. Enteropeptidase converts trypsinogen (a zymogen ) into its active form trypsin , resulting in the subsequent activation of pancreatic digestive enzymes .

  3. Enterocyte - Wikipedia

    en.wikipedia.org/wiki/Enterocyte

    Enteropeptidase (also known as enterokinase) is responsible for activating pancreatic trypsinogen into trypsin, which activates other pancreatic zymogens. They are involved in the Krebs and the Cori Cycles and can be synthesized with lipase. Lipid uptake. Lipids are broken down by pancreatic lipase aided by bile, and then diffuse into the ...

  4. Trypsin inhibitor - Wikipedia

    en.wikipedia.org/wiki/Trypsin_inhibitor

    It is formed in the pancreas and activated to trypsin with enteropeptidase [6] Chymotrypsinogen is the inactive form of chymotrypsin and has similar functions as trypsin. The presence of trypsin inhibitor has been found to result in delayed growth as well as metabolic and digestive diseases. [ 7 ]

  5. Gastrointestinal hormone - Wikipedia

    en.wikipedia.org/wiki/Gastrointestinal_hormone

    Ghrelin agonistic treatments can be used to treat illnesses such as anorexia and loss of appetites in cancer patients. Ghrelin treatments for obesity are still under intense scrutiny and no conclusive evidence has been reached. This hormone stimulates growth hormone release. Amylin controls glucose homeostasis and gastric motility

  6. ATP-dependent Clp protease proteolytic subunit - Wikipedia

    en.wikipedia.org/wiki/ATP-dependent_Clp_protease...

    This can be exploited by therapeutic agents, including by the hyperactivation of ClpP to cause selective cancer cell lethality. [16] Intracellular proteases have a role in bacterial virulence. Deletion of ClpP causes growth inhibition or loss of virulence in many bacterial species which makes them a good target for developing new antimicrobial ...

  7. PD-1 and PD-L1 inhibitors - Wikipedia

    en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors

    In the cancer disease state, the interaction of PD-L1 on the tumor cells with PD-1 on a T-cell reduces T-cell function signals to prevent the immune system from attacking the tumor cells. [9] Use of an inhibitor that blocks the interaction of PD-L1 with the PD-1 receptor can prevent the cancer from evading the immune system in this way. [9]